| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.08B | 15.12B | 18.68B | 21.52B | 15.46B | 8.71B |
| Gross Profit | 2.52B | 2.39B | 2.82B | 4.69B | 3.41B | 3.09B |
| EBITDA | 2.55B | 3.54B | 3.77B | 5.48B | 3.80B | 2.89B |
| Net Income | 907.07M | 955.20M | 1.01B | 2.76B | 2.12B | 2.12B |
Balance Sheet | ||||||
| Total Assets | 42.42B | 42.70B | 42.92B | 42.98B | 32.38B | 20.08B |
| Cash, Cash Equivalents and Short-Term Investments | 4.40B | 5.01B | 5.96B | 6.85B | 2.98B | 3.04B |
| Total Debt | 14.68B | 15.08B | 15.04B | 14.99B | 12.81B | 5.19B |
| Total Liabilities | 19.87B | 20.25B | 21.14B | 20.69B | 18.35B | 8.27B |
| Stockholders Equity | 22.45B | 22.03B | 21.70B | 22.22B | 14.03B | 11.81B |
Cash Flow | ||||||
| Free Cash Flow | 747.39M | 47.12M | 1.03B | -3.65B | -7.89B | -3.19B |
| Operating Cash Flow | 3.07B | 2.85B | 5.91B | 1.97B | 176.90M | 579.73M |
| Investing Cash Flow | -2.99B | -2.88B | -5.55B | -5.83B | -7.87B | -3.56B |
| Financing Cash Flow | -1.21B | -1.19B | -1.35B | 7.00B | 7.85B | 3.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$14.13B | 15.14 | 5.14% | 4.22% | -10.04% | -25.52% | |
62 Neutral | HK$205.72M | 53.04 | 0.62% | 2.34% | -48.30% | -75.98% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | HK$829.19M | 18.00 | -3.78% | ― | -0.28% | -469.70% | |
54 Neutral | HK$35.32B | 116.39 | 4.47% | 5.67% | -9.40% | 163.75% | |
43 Neutral | HK$301.00M | -1.53 | -21.28% | ― | -23.68% | 35.58% | |
38 Underperform | HK$208.48M | -0.49 | 80.94% | ― | -13.39% | 34.49% |